Detalles de la búsqueda
1.
Use of convalescent plasma in COVID-19 patients with immunosuppression.
Transfusion
; 61(8): 2503-2511, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036587
2.
Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib.
Pediatr Blood Cancer
; 67(12): e28712, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991018
3.
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.
Blood
; 129(14): 1919-1926, 2017 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28153823
4.
Bortezomib-based four-drug induction does induce a response in advanced relapsed ALL but cure remains elusive.
Pediatr Blood Cancer
; 67(3): e28115, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820566
5.
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Blood
; 120(2): 285-90, 2012 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22653976
6.
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
J Pediatr Hematol Oncol
; 36(6): 458-63, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24276047
7.
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood
; 118(2): 243-51, 2011 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21562038
8.
Bortezomib Comes to the Rescue: Comment on the Article by Nachmias et al. Entitled "A Bortezomib-Based Protocol Induces a High Rate of CR with Minor Toxicity in Adult Patients with Relapsed/Refractory ALL".
Acta Haematol
; 140(4): 247-249, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30423549
9.
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium.
Pediatr Blood Cancer
; 55(2): 254-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20582937
10.
Medical Cannabis Certification in a Large Pediatric Oncology Center.
Children (Basel)
; 6(6)2019 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31212902
11.
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.
Blood Adv
; 3(11): 1647-1656, 2019 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31160295
12.
Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
J Clin Oncol
; 35(15): 1730-1736, 2017 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28339328
13.
Effective Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole once a day twice a week.
Pediatr Blood Cancer
; 53(2): 239, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19422030
14.
Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis.
F1000Res
; 2: 202, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24795806
15.
Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions.
Pediatr Blood Cancer
; 48(5): 510-4, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16763978
16.
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Pediatr Blood Cancer
; 49(3): 250-5, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16856155
17.
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
J Clin Oncol
; 24(19): 3150-6, 2006 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16717292
18.
Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Pediatr Blood Cancer
; 45(1): 5-9, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15481062
19.
Systemic methotrexate exposure is greater after intrathecal than after oral administration.
J Pediatr Hematol Oncol
; 25(2): 114-7, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12571461
20.
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood
; 101(10): 3809-17, 2003 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12531809